Stockreport

Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF Congruence to receive undisclosed upfront payment as well as R&D funding, milestones and royalties OSAKA, Japan and MONTREAL March 2, 2026 /PRNewswire/ -- Ono Pharmac [Read more]